Compliance to D2 lymphadenectomy in laparoscopic gastrectomy

Eshuis, Wietse J.; Henegouwen, Mark I. van Berge; Draaisma, Werner A.; Gisbertz, Suzanne S.

doi:10.1007/s13304-018-0553-1

Cited by 13 publications

(10 citation statements)

References 39 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Laparoscopic surgery has an advantage over open surgery in minimizing blood loss due to the rapid identification and control of small vessels [10]. In past reports, the estimated blood loss ranged from 82 ml to 333 ml for laparoscopic gastrectomy and 201-440 ml for open procedures [7,[16][17][18][19].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Laparoscopic gastrectomy with D2 lymphadenectomy for gastric cancer: initial Egyptian experience at the National Cancer Institute

Abdelhamed

Abdellatif

Touny

et al. 2020

J Egypt Natl Canc Inst

View full text Add to dashboard Cite

Background: Laparoscopic gastrectomy has been used as a superior alternative to open gastrectomy for the treatment of early gastric cancer. However, the application of laparoscopic D2 lymphadenectomy remains controversial. This study aimed to evaluate the feasibility and outcomes of laparoscopic gastrectomy with D2 lymphadenectomy for gastric cancer. Results: Between May 2016 and May 2018, twenty-five consecutive patients with gastric cancer underwent laparoscopic D2 gastrectomy: eighteen patients (72%) underwent distal gastrectomy, four patients (16%) underwent total gastrectomy, and three patients (12%) underwent proximal gastrectomy. The median number of lymph nodes retrieved was 18 (5-35). A positive proximal margin was detected in 2 patients (8%). The median operative time and amount of blood loss were 240 min (200-330) and 250 ml (200-450), respectively. Conversion to an open procedure was performed in seven patients (28%). The median hospital stay period was 8 days (6-30), and the median time to start oral fluids was 4 days (3-30). Postoperative complications were detected in 4 patients (16%). There were two cases of mortality (8%) in the postoperative period, and two patients required reoperation (8%). Conclusions: Laparoscopic gastrectomy with D2 lymphadenectomy can be carried out safely and in accordance with oncologic principles.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Stations 13-15 are the lymph nodes behind the pancreas and along the superior mesenteric and the middle colic vessels. Station 16 refers to the para-aortic lymph nodes [9,10].…”

Section: Introductionmentioning

confidence: 99%

Laparoscopic gastrectomy with D2 lymphadenectomy for gastric cancer: initial Egyptian experience at the National Cancer Institute

Abdelhamed

Abdellatif

Touny

et al. 2020

J Egypt Natl Canc Inst

View full text Add to dashboard Cite

show abstract

“…Die hohe Präzision durch 3-D-Optik und verbesserte Ergonomie birgt weitere Vorteile, z. B. bei der Lymphknotenresektion im Milzhilus, die laparoskopisch als so schwierig gilt, dass manche Autoren aufgrund des hohen Blutungsrisikos darauf verzichten wollen [7,8].…”

Section: Introductionunclassified

Die roboterassistierte minimalinvasive D2-Lymphadenektomie

et al. 2020

View full text Add to dashboard Cite

“…This could lead to a modification in the TNM (tumor lymph node metastasis) classification of cancer, which could impact prognostic accuracy. [4][5][6] The AJCC-accepted TNM classification is the best prognostic classification approach for assessing the survival of gastric cancer patients in Western countries. In 1997, the number of metastatic lymph nodes (MLN) rather than their location became the basis for lymph node classification.…”

mentioning

confidence: 99%

Does lymph node ratio (metastasis/total lymph node count) affect survival and prognosis in gastric cancer?

TOPÇU

Şahiner

Kendirci

et al. 2022

SMJ

View full text Add to dashboard Cite

Objectives: To investigate the influence of the metastatic lymph node/total lymph node ratio (N-ratio) on survival and prognosis in surgically treated gastric carcinomas. Methods:A retrospective review of 73 patients who underwent curative resection at the Department of General Surgery, Hitit University Faculty of Medicine, Turkey. Receiver operating characteristic analysis was used to calculate the cut-off value for the N-ratio of the patients. The N-ratio cut-off value was determined to be 0.32. Patients were divided into 2 groups: below 0.32 (Group 1) and 0.32 and above 0.32 (Group 2). Original ArticleResults: Group 2 patients had a total lymph node mean of 25.10±13.64 while Group 1 patients had a total lymph node mean of 18.77±9.36 (p=0.04). In Group 2, the mean of metastatic lymph node was 15.97±10.30 (p<0.001). The mortality rate of Group 1 was 18% while Group 2 was 51.7%, and were statistically significant (p=0.0039). The estimated survival duration of Group 2 was 24.22 months, and Group 1 was 48.01 months (p=0.001). The mean estimated survival time for the entire group was 40.92 months. We differentiated patients from the development of mortality cut-off value in ROC analysis with 65.2% sensitivity and 72% specificity. This ratio was found to be 0.32, which was statistically significant (p=0.003). Ratios greater than 0.32 raised the risk of mortality by 4.8 times, which was statistically significant (p=0.003). Conclusion:The N-ratio could be a new metric to evaluate prognosis following curative gastrectomy and improve the existing tumor lymph node metastasis staging system.

show abstract

Compliance to D2 lymphadenectomy in laparoscopic gastrectomy

Cited by 13 publications

References 39 publications

Laparoscopic gastrectomy with D2 lymphadenectomy for gastric cancer: initial Egyptian experience at the National Cancer Institute

Laparoscopic gastrectomy with D2 lymphadenectomy for gastric cancer: initial Egyptian experience at the National Cancer Institute

Die roboterassistierte minimalinvasive D2-Lymphadenektomie

Does lymph node ratio (metastasis/total lymph node count) affect survival and prognosis in gastric cancer?

Contact Info

Product

Resources

About